You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Vitamin D: supplement use in specific population groups

  • Public health guideline
  • Reference number: PH56
  • Published:  26 November 2014
  • Last updated:  30 August 2017
  • Guidance
  • Tools and resources
  • Evidence
  • History

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence

  • Surveillance report

  • December 2025 exceptional surveillance of vitamin D: supplement use in specific population groups (NICE guideline PH46)

  • Surveillance report – Vitamin D: increasing supplement use in at-risk groups (2014) NICE guideline PH56

  • Appendix A: Summary of new evidence from surveillance (PDF 376 KB)

    Published:
    31 July 2017
  • Appendix B: Stakeholder consultation comments table (PDF 466 KB)

    Published:
    31 July 2017
  • Economic analysis

  • Economic evaluation - final (PDF 996 KB)

    Published:
    26 November 2014
  • Evidence review

  • Evidence review 1 (PDF 1.84 MB)

    Published:
    26 November 2014
  • Evidence review 2 (PDF 1.01 MB)

    Published:
    26 November 2014
  • Evidence statement

  • Evidence statements (PDF 145 KB)

    Published:
    26 November 2014
Back to top